Bharat Biotech's Covaxin third phase trial proven successful
The third phase trial of India's indigenous vaccine Covaxin has proven successful. Bharat Biotech vaccine was tested in twenty-five cities of the country. Covaxin has shown to be 81% efficacy in trials. ICMR tweeted that it was a big win for self-reliant India.
